Cytodyne Technologies

June 12 2003

A verdict has been found in the class action lawsuit filed against Cytodyne Technologies on behalf of consumers. The court has ordered the company to pay $12,536,820, the amount identified as "obtained by means of unlawful practice." The suit alleged that the companies advertisements for its ephedra-based Xenadrine RFA-1 diet products were deceptive. (May-30-03) [EMAIL LAW FIRM]

Legal Help

If you have a similar problem and would like to be contacted by a lawyer at no obligation, please fill in the form to the right to submit your complaint.
Lawyers click here to submit your settlements and verdicts to have them published for free on our websites

Add Your Comment on This Issue

Fields marked * are mandatory. Please read our comment guidelines before posting.


Note: Your name will be published with your comment.

*Email Address:

Your email will only be used if a response is needed.

*Your Comment: